DNA X Statistics
Total Valuation
DNA X has a market cap or net worth of $4.75 million. The enterprise value is $3.39 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DNA X has 1.49 million shares outstanding. The number of shares has increased by 107.24% in one year.
| Current Share Class | 1.49M |
| Shares Outstanding | 1.49M |
| Shares Change (YoY) | +107.24% |
| Shares Change (QoQ) | +86.41% |
| Owned by Insiders (%) | 13.27% |
| Owned by Institutions (%) | 9.50% |
| Float | 1.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 0.11 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60
| Current Ratio | 0.60 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -8.08% |
| Return on Invested Capital (ROIC) | -3,507.70% |
| Return on Capital Employed (ROCE) | 130.93% |
| Weighted Average Cost of Capital (WACC) | 13.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$157,687 |
| Employee Count | 131 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.13% in the last 52 weeks. The beta is 1.72, so DNA X's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | -89.13% |
| 50-Day Moving Average | 4.45 |
| 200-Day Moving Average | 8.30 |
| Relative Strength Index (RSI) | 41.12 |
| Average Volume (20 Days) | 79,147 |
Short Selling Information
The latest short interest is 72,972, so 4.90% of the outstanding shares have been sold short.
| Short Interest | 72,972 |
| Short Previous Month | 66,171 |
| Short % of Shares Out | 4.90% |
| Short % of Float | 6.17% |
| Short Ratio (days to cover) | 1.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.41M |
| Pretax Income | -7.96M |
| Net Income | -20.66M |
| EBITDA | -1.11M |
| EBIT | -5.41M |
| Earnings Per Share (EPS) | -$28.58 |
Full Income StatementBalance Sheet
The company has $1.30 million in cash and n/a in debt, with a net cash position of $1.30 million or $0.88 per share.
| Cash & Cash Equivalents | 1.30M |
| Total Debt | n/a |
| Net Cash | 1.30M |
| Net Cash Per Share | $0.88 |
| Equity (Book Value) | -6.73M |
| Book Value Per Share | -6.29 |
| Working Capital | -19.12M |
Full Balance SheetCash Flow
| Operating Cash Flow | -23.53M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3.39M |
| Net Borrowing | 5.11M |
| Free Cash Flow | -26.04M |
| FCF Per Share | -$17.50 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
